Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Aortic Regurgitation I: Introduction

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Aneurysm I: Introduction

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.

American journal of hematology·2026

Same author

Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids.

Nature reviews. Rheumatology·2026

Same author

Significance of positive rheumatoid factor in ANCA-associated vasculitis.

Clinical and experimental rheumatology·2026

Same author

Structured Vascular Segment Analysis for Giant Cell Arteritis: A Proposed Scoring System for CT Angiography-Based Diagnosis.

AJNR. American journal of neuroradiology·2026

Same author

A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis.

Seminars in arthritis and rheumatism·2026

Same author

Do Not Anchor on Vasculitis: Pancreatic Cancer Presenting With Isolated Celiac/Superior Mesenteric Artery Thickening.

ACR open rheumatology·2026

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Mouse Models for Graft Arteriosclerosis

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Aortic disease in giant cell arteritis.

Kenneth J Warrington¹

¹Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

Seminars in Arthritis and Rheumatism

|February 28, 2025

Summary

Giant cell arteritis (GCA) significantly increases the risk of aortic disease, including inflammation and aneurysms. Early detection via vascular imaging is crucial for managing this serious complication.

Area of Science:

Vascular Medicine
Rheumatology
Cardiovascular Imaging

Background:

Vasculitis, particularly Giant Cell Arteritis (GCA), frequently involves the aorta, with up to 70% showing radiographic evidence of aortitis at onset.
Aortic dilatation is present in about 15% of GCA patients, posing a risk for aneurysm formation and dissection.
Aortitis can be asymptomatic, highlighting the need for advanced imaging in early detection and management.

Purpose of the Study:

To review the role of non-invasive vascular imaging in detecting aortic disease in vasculitis patients.
To discuss the pathogenesis, clinical implications, and management strategies for GCA-associated aortic disease.
To emphasize the importance of understanding disease mechanisms for developing targeted therapies.

Main Methods:

Keywords:

Aneurysm Aortitis Giant cell arteritis Takayasu arteritis Vasculitis

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

Mouse Models for Graft Arteriosclerosis

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Porcine Model of Infrarenal Abdominal Aortic Aneurysm

Published on: November 21, 2019

Review of current literature on aortic disease in GCA and Takayasu arteritis.
Analysis of diagnostic imaging modalities including CT angiography, MR angiography, and FDG-PET.
Inclusion of insights from observational, transcriptomic, and molecular studies on aortic tissue.

Main Results:

GCA patients have a significantly elevated risk (up to 17-fold) of thoracic aortic aneurysms.
About one-third of GCA patients may develop aortic aneurysms within 10 years.
Chronic aortitis can be refractory to treatment, leading to progressive dilatation and potential rupture or dissection.

Conclusions:

Non-invasive imaging is vital for early detection and monitoring of aortic complications in GCA.
Improved understanding of aortitis pathogenesis is key to developing novel, non-glucocorticoid therapies.
Reducing mortality from GCA-related aortic disease requires integrated management and ongoing research.